Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

Janaki Medical College Journal of Medical Sciences with ISSN number 2091-2242 (Print) and 2091-2358 (Online) publishes original articles, review articles, case reports, letter to editor and book review-all of which are submitted to peer-review. An article is reviewed by an expert of the subjects for publication assuming that its contents have not been published or submitted simultaneously to any other journal. Any attempt at dual publication will lead to rejection and will penalize the authors by not accepting article in future. Articles and their illustrations become the property of journal unless are reserved before publication. Any false reporting by author is the responsibility of the author not of the journal.

The Manuscript is to be prepared in accordance with “Uniform requirements for Manuscripts submitted to Biomedical Journals” developed by the International Committee of Medical Journal Editors (October 2006) and must be submitted in clear and concise English to the Editor-in-chief.

Please submit the article in accordance to the ‘guidelines to authors’ on following mailing address:

Editor-in-chief
Janaki Medical College Journal of Medical Sciences (JMCJMS)
Janaki Medical College
Ramdaiya, Janakpurdham, Nepal
Email: editorjmcjms@gmail.com

The editorial process

The manuscripts will be reviewed for possible publication with the understanding that they are being submitted to one journal at a time and have not been published, simultaneously submitted or already accepted for publication elsewhere.

The editors will review all submitted manuscripts that is in accordance with the guidelines of JMCJMS.  Manuscripts with insufficient originality, serious scientific and technical flaws, or lacking a significant message are rejected.  If good articles are written poorly then the authors are requested to re- submit after revision according to the JMCJMS format.  All manuscripts received are duly acknowledged. They are sent to two expert reviewers without revealing the identity of the contributors.

The JMCJMS editors review each manuscript meticulously based on the comments from the reviewers and make a final decision to either reject or publish it. The contributors will be informed about the reviewers’ comments, acceptance or rejection of the manuscript.

Articles accepted will be copy edited for grammar, punctuation, print style and format. Page proofs will be sent to the corresponding author, which has to be returned to the editorial office within seven days. Non response may delay the publication of the article or even result in being rejected.

Types of manuscript and word limits

Original Article:

Original articles should not exceed 5000 words. It should not exceed 24 pages double-spaced typewritten pages, including tables, figures and references.  The references should be limited to 30.  Abstracts should not exceed 350 words.  Manuscripts submitted as original articles that exceed these limits will be returned without review at the discretion of the editorial board. Original Articles should have following headings in its manuscript:

Title, Abstract, Key Words, Introduction, Methodology, Results, Discussion, Conclusion, Acknowledgement (Not always), References

Title: Title should be short and give an impression of the paper. It should not exceed 30 words.

Abstracts: The abstract should contain the essence of the whole paper and should stand-alone. It should be concise and clear. Please be sure on following points while preparing Abstract of the article:

  • Word limits – 350 words
  • No abbreviation to be used in abstract
  • Structured abstract - into following sub groups:
    • Background and Objectives , Methodology, Results, Conclusion

Key Words

Key Words – 3-7 words, arranged in alphabetical order. These words should the follow MeSH list.

Introduction

Provide the context or background of the study. State the purpose or the research objectives of the paper clearly. Do not review the subject extensively and give only pertinent references.

Materials and Methods

The materials and methods section should only include information that was available at the time that the study was planned or the protocol written.  All information obtained during the conduct of the study should be written in the results section.

Selection and Description of Participants

Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population.  Because the relevance of such variables as age and sex to the object of research is not always clear, authors should explain their use when they are included in a study report. For example, authors should explain why only subjects of certain ages were included or why women were excluded. The guiding principle should be clarity about how and why a study was done in a particular way. When authors use variables such as race or ethnicity, they should define how they measured the variables and justify their relevance.

Technical information

Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods.  Provide references and brief descriptions for methods that have been published but are not well known. Describe new or substantially modified methods, give reasons for using them and evaluate their limitations. Precisely identify all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

Ethical issues

Evidence of approval by a local Ethics Committee (for both human and animal) must be supplied by the authors on demand.  

Statistics

Describe statistical methods with enough detail to enable a reader with access to the original data to verify the reported result. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as P values. These fail to convey important information such as the effect of the size of the population. References for the design of the study and statistical methods should be to standard procedures when possible. Define statistical terms, abbreviations, and symbols. Specify the computer software used.

Results

Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat all the data of the tables or the illustrations in the text.  When data are summarized in the Results section, give numeric results not only as derivatives (for example percentage), but also the absolute numbers from which the derivatives were calculated. Specify the statistical methods that were used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess the supporting data. Use graphs as an alternative to tables that require many entries.  Do not duplicate data in graphs and tables.  Avoid non technical uses of technical terms in statistics, such as “random” (which implies randomizing device), “normal”, “significant”, “correlations” and “sample”. Where scientifically appropriate, analysis of the data by such variables as age and sex should be included.

Discussion

Emphasize the new and important aspects of the study and the conclusions that follow from them.  Do not repeat in detail the data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings. Compare and contrast the results with the study, and explore the implications of the findings for future research and for clinical practice.

Conclusion
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions that are not adequately supported by the data. You can provide the future implications, future direction and limitation of the study too. As other journal, conclusion can also be included in last paragraph of Discussion section.

Acknowledgments
Acknowledgement should state the person(s)/firms that the author is required to acknowledge.

References

The Vancouver system of referencing should be used.  Authors are responsible for the accuracy of each reference and checking them against the original article.  Provide a list of references, double-spaced, after the text.  Cite references in the text using [ ] bracket and Arabic numerals in the order in which they appear in the text.  Abbreviate titles of journals according to MEDLINE.

Like: text [1, 2, 3].

Examples:

  1. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2002; 9:279-81. [upto six authors]
  2. Stippler M, Crago E, Levy EI et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006; 105:723-9. [for more than six authors, mention first 3 authors followed by et al.]

For Book

Author(s) – Family name and initials, editor. Title of Book. Volume. Publisher: Where published;year published. page(s)

Smith JB, editor. Pathology of the lung. Vol 18 3rd ed. John Green Co: Montreal; 1970. 179pp.

Chapter in a Book

Author(s) – Family name and initials. Title of Chapter, In: Title of Book. Publisher: Where published; year published. page(s).

Brown AB, Green XY.  Jejunal pathology, In: Black CD, White EF, (eds). Gastrointestinal pathology; an introduction. 2nd edn. Raven: New York; 1995. pp 465-469.

For Electronic citations

Author. Title of publication [type of medium – Internet]. Place of publication (if available): Publisher (if available); Date of publication – year month day (supply year if month and day not available) [updated year month day; cited year month day]. Available from: web address.

Clea Japan [homepage on the Internet]. Osaka: Clea Japan, c1999-2004. (Cited 25 November 2004) Inbred animals. Available from: http://www.clea-japan.co.jp/animals/b6-3.htm.

Abbreviations and Symbols

Use only standard abbreviations.  Please refer to Proc Natl Acad Sci USA, 92: vii-x (1995) for guidance as to which abbreviations are considered standard. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. Do not use abbreviations like @ or & in the text.

Legends

Put tables, charts, and figures at the end of the paper, after references

Use Legends as: Table e.g. (Table 1) and Figure e.g. (Figure 3).

Review Article:  Review articles should not exceed 6000 words and 35 double-spaced typewritten pages, including tables, figures and references.  The number of references should be limited to 50 (if more than that, justification needed). It should contain abstract, Introduction, Main body text (with headings and subheadings as required), conclusion and future direction.

Theoretical Research article: It should not exceed 6000 words and 35 double-spaced typewritten pages, including tables, figures and references. The number of references should be limited to 50 (if more than that, justification needed). It should contain abstract, Introduction, Main body text (with headings and subheadings as required), conclusion and future direction. Conclusion and future direction is mandatory in such article.

Case report:  Case reports must provide new information. Clinically significant observations based on new or developing technology will receive special consideration. Brevity is required.  Case studies must not be more than 2500 words 10 double spaced typed pages, including tables, figures and references.  The number of references should be 15 or less and the number of figures should be 3 or less. Justify if more is most. Abstracts should not exceed 150 words.  It should contain: Introduction, Case, Discussion and Conclusion. Manuscripts submitted as case studies that do not conform to these requirements will be returned without review.

Letters to the editor: Letters to the editor should contain a brief abstract that is short and decisive. They should not be preliminary observations that require a paper for later validation. They should not be more than 500 words and be limited to 5 references.

Limits for the number of images and tables:  For all the above mentioned categories the number of images and tables should not be more than one per 500 words.

All contributions except Letters to the Editor should contain a brief abstract; full length manuscript should not exceed 250 words; Case report abstract should not exceed 150 words.

All types of Manuscript should have title page and the title page should contain:

  1. Type of manuscript (e.g. Original article, Case report, Review Article etc.)
  2. The title of the article, which should be concise, but informative;
  3. Running title or short title not more than 50 characters;
  4. The name by which the author is known (Last name, First name and Middle name)
  5. The name of the department and institution to which the work should be attributed.
  6. The name, address, phone number, fax-number. email address of the contributors for correspondence about the manuscript;
  7. Source(s) of support in the form of grants, equipments, drugs, or all of these;

Authors name should not be present on other pages than title page

Training Report

 

 

 

Medical Education

 

 

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)